Johnson and Johnson are working very hard to capture a good...

Johnson and Johnson are working very hard to capture a good segment of the market in China. As the sole strip provider for the Lifescan product the future seems very bright.

http://globenewswire.com/news-relea...e-Growth-of-Diabetic-Care-Devices-Market.html

http://www.counterpunch.org/2015/07/24/the-increasing-burden-of-diabetes-in-china/

Forget BAL with 114 million diabetics (and growing) UBI is in the box seat to fly next year.

Even if the Lifescan final payment comes in (most likely in 2017), a reasonable assumption (based on very moderate quarter on quarter growth) will be that it will be at least $50Million USD which is not too far off the  current market cap of the company.